Homepage - Ophthalmology Advisor
Researchers and experts detail the links between ocular conditions and attention deficit hyperactivity disorder, as well as its associated behaviors such as chronic eye rubbing, in both children and adults.
Sickle Cell Raises Retinal Artery, But Not Vein, Occlusion Risk ...
Jul 23, 2024 · Patients with sickle cell disease (HbSS) are at greater risk of experiencing retinal vascular occlusions — specifically retinal arterial occlusions (RAO), according to research presented at the American Society of Retinal Specialists. held in …
Macular Telangiectasia Type 2 Implant Has Strong Tolerability ...
Oct 18, 2024 · Intraocular implantation of NT-501 (Neurotech Pharmaceuticals, Inc.) — a cell therapy treatment for patients with macular telangiectasia type 2 — is well-tolerated and correlates with a lower percentage of eyes with ellipsoid zone (EZ) loss, according to a poster presented at the American Academy of Ophthalmology’s 2024 Annual Meeting held in Chicago, from October 18 to 21, 2024.
Treating Thyroid Eye Disease: This Is Not Graves!
Until recently, there was no pharmaceutical agent approved by the US Food and Drug Administration (FDA) specifically for the treatment of thyroid eye disease (TED), a rare autoimmune disorder with an annual incidence of 1.9 cases for every 10,000 people. 1,2 Also known as Graves orbitopathy and thyroid-associated ophthalmopathy, TED develops in approximately 25% to 40% of people with Graves ...
Restoring the Retina: Coming Advancements to Repair Structure …
Feb 16, 2021 · The ophthalmic literature is replete with studies that open with frightening statistics on the rapid expansion of retinal diseases. Researchers frequently identify age-related macular degeneration (AMD) as the leading cause of blindness in the United States.
Intraocular Lens Choice Dependent on Lifestyle, Expectations ...
Oct 4, 2024 · Cataract surgeons are responsible for advising patients on a decision that will have lifelong implications. Identifying the intraocular lens (IOL) choice most suited for a particular patient’s lifestyle should be done with the patient’s careful consideration, and full understanding of the portfolio of options before them.
Ocular Myasthenia Gravis Treatment Options Explained
Jul 20, 2023 · Myasthenia gravis (MG) can occur in 2 forms: a generalized myasthenia gravis (GMG) or purely ocular myasthenia gravis (OMG). Ocular myasthenia gravis is characterized by progressive fatigability of skeletal muscle limited to the orbicularis oculi, levator palpebrae superioris, and the extraocular muscles. 1 Up to half of patients diagnosed with MG present with ocular muscle weakness before ...
Uveitis Burden in The US Higher Than Previously Believed ...
Oct 20, 2024 · The uveitis burden may be higher in the United States than previously thought. Uveitis is associated with approximately a quarter of all cases of legal blindness, and the disease’s prevalence within the United States appears to be larger than earlier studies suggest, according to research presented at the American Academy of Ophthalmology, held in Chicago, October 18 to 21, 2024.
FDA Alerts: Ophthalmology Drug and Device Approvals
Feb 20, 2024 · Drug Regulatory Updates. Susvimo: Diabetic Eye Conditions. The FDA has accepted the application for Susvimo ® (ranibizumab injection, Genentech) to treat diabetic macular edema (DME) and diabetic retinopathy (DR) based on 1-year Pagoda and Pavilion study data. 3 Susvimo is a refillable implant that delivers medication continuously. 3. Based on 2 years of Phase 3 data presented at American ...
Stent Implant Efficacy Higher Without Cataract Surgery
Jun 25, 2024 · The Xen 45 gel stent implant provides effective, long-term treatment for open-angle glaucoma but there is a substantial rate of reoperation and needling, according to research published in British Journal of Ophthalmology.. The FDA approved the Xen 45 gel stent implant through the 510k pathway.
Skip to content